These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 8705123)

  • 21. [Methadone, maintenance program and reduction of drug abuse. An expanding practice].
    Tremblay M
    Perspect Infirm; 2005; 2(3):40-1. PubMed ID: 15686211
    [No Abstract]   [Full Text] [Related]  

  • 22. Substance abuse and HIV infection.
    Francis H
    Top HIV Med; 2003; 11(1):20-4. PubMed ID: 12717047
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuropsychological impairment among asymptomatic HIV-positive former intravenous drug users.
    Rodríguez Salgado D; Rodríguez Alvarez M; Seoane Pesqueira G
    Cogn Behav Neurol; 2006 Jun; 19(2):95-104. PubMed ID: 16783132
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Opiate agonist maintenance treatment for injecting drug user peer educators.
    Des Jarlais DC; Hammett TM; Wei L; Van LK; Donghua M; Ngu D
    Addiction; 2004 Oct; 99(10):1355-6. PubMed ID: 15369577
    [No Abstract]   [Full Text] [Related]  

  • 25. Commentary on Uhlmann et al. (2010): managing HIV in drug users--the huge gap remaining between evidence and international policy and practice.
    Carrieri MP; Wodak A
    Addiction; 2010 May; 105(5):914-5. PubMed ID: 20402976
    [No Abstract]   [Full Text] [Related]  

  • 26. Opiate-dependent patients receiving methadone. How physicians should manage therapy.
    Kahan M; Sutton N
    Can Fam Physician; 1996 Sep; 42():1769-78. PubMed ID: 8828879
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antiretroviral adherence and HIV treatment outcomes among HIV/HCV co-infected injection drug users: the role of methadone maintenance therapy.
    Palepu A; Tyndall MW; Joy R; Kerr T; Wood E; Press N; Hogg RS; Montaner JS
    Drug Alcohol Depend; 2006 Sep; 84(2):188-94. PubMed ID: 16542797
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Methadone maintenance treatment (MMT) in general practice or in specialized centers: profile of patients in the Swiss Canton of Vaud.
    Pelet A; Doll S; Huissoud T; Resplendino J; Besson J; Favrat B
    Am J Drug Alcohol Abuse; 2007; 33(5):665-74. PubMed ID: 17891659
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Methadone treatment and needle use prevention.
    Iguchi M
    Focus; 2002 Feb; 17(3):5-6. PubMed ID: 11968160
    [No Abstract]   [Full Text] [Related]  

  • 30. [Complementary prevention actions as a means of reducing risks].
    Ingold FR
    Ann Med Interne (Paris); 1994 Nov; 145 Suppl 3():71-2. PubMed ID: 7880030
    [No Abstract]   [Full Text] [Related]  

  • 31. [Methadone in the United States. The states and risk reduction].
    Touzeau D; Arnold-Richez F
    Soins; 1997; (612):19-22. PubMed ID: 9110882
    [No Abstract]   [Full Text] [Related]  

  • 32. [Clinical and epidemiologic aspects of HIV infection among drug addicts in Ho Chi Minh city].
    Nguyen HC
    Sante; 1996; 6(2):73. PubMed ID: 8705128
    [No Abstract]   [Full Text] [Related]  

  • 33. Profiles of self-reported HIV-risk behaviors among injection drug users in methadone maintenance treatment, detoxification, and needle exchange programs.
    Mark HD; Nanda J; Davis-Vogel A; Navaline H; Scotti R; Wickrema R; Metzger D; Sochalski J
    Public Health Nurs; 2006; 23(1):11-9. PubMed ID: 16460416
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adherence to HIV treatment among IDUs and the role of opioid substitution treatment (OST).
    Spire B; Lucas GM; Carrieri MP
    Int J Drug Policy; 2007 Aug; 18(4):262-70. PubMed ID: 17689374
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Subjective Quality of Life in opiate-dependent patients before admission after six months and one-year participation in methadone program].
    Habrat B; Chmielewska K; Baran-Furga H; Keszycka B; Taracha E
    Przegl Lek; 2002; 59(4-5):351-4. PubMed ID: 12184005
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluating the impact of methadone maintenance programmes on mortality due to overdose and aids in a cohort of heroin users in Spain.
    Brugal MT; Domingo-Salvany A; Puig R; Barrio G; García de Olalla P; de la Fuente L
    Addiction; 2005 Jul; 100(7):981-9. PubMed ID: 15955014
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Drug misuse.
    Ashworth AJ; Kidd BA
    Br J Gen Pract; 1998 Jul; 48(432):1435-6. PubMed ID: 9800413
    [No Abstract]   [Full Text] [Related]  

  • 38. [Effect of methadone or naltrexone on the course of transaminases in parenteral drug users with hepatitis C virus infection].
    Lozano Polo JL; Gutiérrez Mora E; Martínez Pérez V; Santamaría Gutiérrez J; Vada Sánchez J; Vallejo Correas JA
    Rev Clin Esp; 1997 Jul; 197(7):479-83. PubMed ID: 9411543
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effectiveness of methadone treatment in reducing HIV risk behavior and HIV seroconversion among injecting drug users.
    Gibson DR; Flynn NM; McCarthy JJ
    AIDS; 1999 Oct; 13(14):1807-18. PubMed ID: 10513638
    [No Abstract]   [Full Text] [Related]  

  • 40. Methadone treatment in an intermediate care setting?
    Wayte C
    Br J Gen Pract; 2003 Oct; 53(495):808; author reply 808. PubMed ID: 14601360
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.